Product Information
NITROGLYCERIN 0.4 MG TABLET SL is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1272 per EA under NDC 59651065804. Its NADAC has been published 122 times since Jun 5, 2024.
FDA first approved this application on Oct 26, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.4 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651065804
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
9/23/2026
Active Ingredients
NITROGLYCERINApproval Type
Generic (ANDA)
FDA Application
ANDA217879FDA Approved
10/26/2023
TE Code
AB
On Market Since
10/26/2023
Pharmacological Classes
Price Statistics
The NADAC for NITROGLYCERIN 0.4 MG TABLET SL has been published 122 times since Jun 5, 2024, and over the history we have for it it has declined 29.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1272 per EA |
|---|---|
| All-time high | $0.2543 (Sep 11, 2024) |
| All-time low | $0.1272 (Sep 23, 2026) |
| 52-week high | $0.1681 |
| 52-week low | $0.1272 |
| Median price | $0.1681 |
| Average price | $0.1717 |
| Largest weekly change | -23.8% (Oct 23, 2024) |
| Weeks tracked | 122 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NITROGLYCERIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrate Vasodilator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NITROGLYCERIN 0.4 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for NITROGLYCERIN 0.4 MG TABLET SL, manufactured by Aurobindo Pharma Limited, is $0.1272 per EA (NDC 59651065804), effective Sep 30, 2026.
How has the price of NITROGLYCERIN 0.4 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for NITROGLYCERIN 0.4 MG TABLET SL has declined 29.5%. It has been tracked across 122 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for NITROGLYCERIN 0.4 MG TABLET SL?
Since Jun 5, 2024, the NADAC for NITROGLYCERIN 0.4 MG TABLET SL has ranged from a low of $0.1272 (Sep 23, 2026) to a high of $0.2543 (Sep 11, 2024), with a median of $0.1681 per EA.
Are there cheaper alternatives to NITROGLYCERIN 0.4 MG TABLET SL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NITROGLYCERIN 0.4 MG TABLET SL, is $0.0787 per EA — about 38% below NITROGLYCERIN 0.4 MG TABLET SL.
Who manufactures NITROGLYCERIN 0.4 MG TABLET SL?
NITROGLYCERIN 0.4 MG TABLET SL (NDC 59651065804) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.